Oxygen-Inhibited Photopolymerization for Tunable Hydrogel Particle Morphology
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The inhibition of photopolymerization of PEGDA by oxygen limits the formation of hydrogel particles in high oxygen concentration environments, hindering applications in drug delivery and tissue engineering, and existing methods for producing non-spherical particles are limited by device geometry and capillary pressure.
Innovation Solution
The method involves using oxygen-inhibited photopolymerization within microfluidic devices to control the size and shape of hydrogel particles by manipulating oxygen diffusion and UV exposure, allowing for the production of particles with tunable crosslinking density and non-spherical shapes, such as rods and wires, by controlling the unpolymerized shell thickness and channel dimensions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If photopolymerization is performed in high oxygen concentration environments, then polymerization rate increases, but polymerization is inhibited and hydrogel formation is frustrated
Solution Approach 1:
The patent exploits oxygen inhibition as a beneficial mechanism to control polymerization. By allowing oxygen to diffuse into microdroplets during photopolymerization, the unpolymerized shell forms a protective layer that enables precise control of particle size and shape. The harmful oxygen inhibition is converted into a useful tool for generating microparticles with customizable properties.
Solution Approach 2:
The patent creates spatially heterogeneous polymerization by allowing oxygen to penetrate from the droplet surface inward. This results in a gradient structure where the outer shell remains unpolymerized while the core polymerizes, creating particles with distinct interfacial and bulk properties. The local oxygen concentration varies throughout the droplet, enabling localized control of polymerization.
2Shape
If conventional methods are used to produce non-spherical particles, then particle shape control is achieved, but device geometry and capillary pressure limit the range of shapes and sizes
Solution Approach 1:
Instead of using complex device geometries to constrain droplets into specific shapes, the patent inverts the approach by allowing droplets to maintain simple spherical shapes during formation, then using controlled oxygen diffusion and photopolymerization to sculpt the final particle shapes. The unpolymerized shell thickness and UV exposure parameters control the final morphology rather than the device geometry.
Solution Approach 2:
The patent achieves shape control by varying process parameters such as UV exposure intensity, exposure time, oxygen concentration, and photoinitiator concentration rather than changing device geometry. By adjusting these parameters, a wide range of particle shapes and sizes can be generated from simple spherical microdroplets without requiring complex microfluidic device designs.
3Manufacturing precision
If microdroplet size is reduced to produce smaller microparticles, then particle size control improves, but oxygen diffusion becomes more difficult and polymerization is further inhibited
Solution Approach 1:
The patent incorporates oxygen into the microdroplet formulation before photopolymerization begins. This preliminary oxygen loading ensures that sufficient oxygen is available throughout the droplet volume to inhibit polymerization in the desired regions, even in small droplets where diffusion distances are short. The pre-loaded oxygen works in conjunction with controlled diffusion during the polymerization process.
Solution Approach 2:
The patent uses the microdroplet as a template or copy that defines the maximum size of the final microparticle. By controlling the unpolymerized shell thickness through oxygen inhibition, the actual particle size is determined as a scaled-down version of the original droplet size. This copying mechanism enables precise size control while the oxygen inhibition mechanism adapts to the smaller scale.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the generation of hydrogel particles with precise control over size and shape, overcoming the limitations of existing methods and enhancing their suitability for drug delivery and tissue engineering applications by creating particles with customizable mechanical properties and surface chemistry.
Implementation Method 1
oxygen is diffused through the non-aqueous phase into the microdroplets
Implementation Method 2
partially polymerizing the aqueous phase thereby generating a microparticle within the aqueous phase
Data Source
AI summary
Described are methods and devices for the generation of hydrogel particles with micrometer and submicrometer dimensions using oxygen-inhibited partial polymerization, and the particles generated therefrom. The described methods generate particles with dimensions independent of the starting polymerizable solution dimension, for example, a microdroplet. Further, microfluidic flow parameters (e.g. viscosity, flow rate) and photopolymerization process parameters (e.g. optical exposure intensity and duration) are controlled to generate particles with tunable crosslinking density-determined properties including elasticity, diffusivity, and biomolecular display for diverse applications such as drug delivery, tissue engineering cell scaffolds, and single- and multiple-cell therapeutics. Similarly, gradients of crosslinking density-determined properties can be created within single particles through the selection of optical exposure intensity and duration. In addition to conventional spherical shapes, a suite of non-spherical shapes may be generated by manipulating the dimensions of the microfluidic channels and other related physical and process parameters.